Goldman Sachs Upgrades BioNTech on Promising Cancer Drug BNT327

Goldman Sachs has upgraded BioNTech (BNTX) to Buy, citing the company’s BNT327, an immuno-oncology asset in clinical development. Data from Summit Therapeutics and Akeso for ivonescimab (PD-1xVEGF bispecific) has shown potential to challenge standard-of-care regimens across various solid tumors, sparking interest in BioNTech’s bispecific drug. Goldman analysts believe BNT327 has the potential to drive BioNTech toward becoming a leading player in oncology, making current stock levels an attractive entry point for investors.

Royal Caribbean Cruises (RCL) Stock Rises Despite Mixed Q3 Results, Focus Shifts to Cost Management

Royal Caribbean Cruises (RCL) stock gained over 3% on Tuesday despite reporting mixed third-quarter results. While revenue exceeded expectations, adjusted earnings per share (EPS) beat estimates but fell short of investor expectations due to anticipated cost increases. Goldman Sachs analyst Lizzie Dove highlights the impact of Hurricane Milton and a shift in cost timing on the fourth-quarter outlook, but remains optimistic about the company’s long-term fundamentals.

Goldman Sachs Predicts Low S&P 500 Returns: Experts Weigh In

Goldman Sachs’ prediction of a meager 3% annualized return for the S&P 500 over the next decade has sparked debate among Wall Street experts. While some agree that such low returns are possible, others argue that robust earnings growth driven by technological advancements will fuel stronger market performance. This article explores the contrasting viewpoints, analyzes historical data, and ultimately emphasizes the inherent difficulty in predicting future market behavior.

Wall Street Week in Review: Bulls and Bears Clash Amidst Election Uncertainty

This week on Wall Street, the markets saw mixed signals, with the S&P 500 and Dow ending their six-week winning streaks, while the Nasdaq reached an all-time high. Investor caution and concerns about fiscal policies and potential trade disruptions following the upcoming presidential election led to a flat week overall. This report dives into the top bullish and bearish calls from Benzinga, highlighting key trends and investor sentiment.

Scroll to Top